Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Real Life Experience With Caduet [amlodipine/atorvastatin] Evaluating Effectiveness, Safety And Tolerability In The Management Of Cardiovascular Risk Factors (EXCEL Study)

Next Previous
X
Search
Trial Profile

Real Life Experience With Caduet [amlodipine/atorvastatin] Evaluating Effectiveness, Safety And Tolerability In The Management Of Cardiovascular Risk Factors (EXCEL Study)

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amlodipine/atorvastatin (Primary)
  • Indications Dyslipidaemias; Hypertension
  • Focus Therapeutic Use
  • Acronyms EXCEL
  • Sponsors Pfizer

    • Most Recent Events

    • 24 Jun 2009 Actual initiation date changed from Jan 2008 to Dec 2007, patient number chnaged from 143 to 112 as reported by ClinicalTrials.gov.
    • 24 Jun 2009 Primary endpoint changed to systolic and diastolic blood pressure as reported by ClinicalTrials.gov.
    • 05 May 2008 Status changed from initiated to discontinued and actual patient numbers updated as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top